Condition
Mesothelioma
Estimated Enrollment: 77
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: ONC-2006-003|EUDRACT 2006-004429-27
Study First Received: December 4, 2006
Last Updated: August 31, 2011
Estimated Primary Completion Date: November 2010
Primary Outcome Measures:
Time to progression (TTP) from first day of treatment until first observation of disease progression or death due to any cause or the last date the patient was known to be progression free or alive.|Response rate (RR) assessed according to modified RECIST criteria for Malignant Pleural Mesothelioma.|Overall survival (OS) computed as the time between the first day of treatment and the date of death or the last date the patient was known to be alive.
Sponsors and Collaborators:
Armando Santoro, MD|Istituto Clinico Humanitas
Website Link: https://ClinicalTrials.gov/show/NCT00407459
